Robert L. Haining - Search Results

Year	Number of Results
2002	4
2003	1
2004	1
2005	1
2006	3
2007	1
2008	1
2009	1
2016	1
2017	1
2019	1
2024	0

1

Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator.

Haining RL, Achat-Mendes C. Haining RL, et al. Neural Regen Res. 2017 Mar;12(3):372-375. doi: 10.4103/1673-5374.202928. Neural Regen Res. 2017. PMID: 28469642 Free PMC article. Review.

2

Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?

Haining RL, Nichols-Haining M. Haining RL, et al. Pharmacol Ther. 2007 Mar;113(3):537-45. doi: 10.1016/j.pharmthera.2006.11.005. Epub 2006 Dec 20. Pharmacol Ther. 2007. PMID: 17270273 Review.

3

The human intestinal cytochrome P450 "pie".

Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. Paine MF, et al. Among authors: haining rl. Drug Metab Dispos. 2006 May;34(5):880-6. doi: 10.1124/dmd.105.008672. Epub 2006 Feb 7. Drug Metab Dispos. 2006. PMID: 16467132 Free PMC article.

4

Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy.

Fink J, Pathak H, Smith J, Achat-Mendes C, Haining RL. Fink J, et al. Among authors: haining rl. Biomolecules. 2019 May 8;9(5):175. doi: 10.3390/biom9050175. Biomolecules. 2019. PMID: 31072013 Free PMC article.

5

Expression, purification, and characterization of mouse CYP2d22.

Yu AM, Haining RL. Yu AM, et al. Among authors: haining rl. Drug Metab Dispos. 2006 Jul;34(7):1167-74. doi: 10.1124/dmd.105.008870. Epub 2006 Apr 4. Drug Metab Dispos. 2006. PMID: 16595712

6

Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Haining RL, Jones TM, Hernandez A. Haining RL, et al. Neurochem Res. 2016 Dec;41(12):3356-3363. doi: 10.1007/s11064-016-2068-9. Epub 2016 Sep 23. Neurochem Res. 2016. PMID: 27662849

7

CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.

Bland TM, Haining RL, Tracy TS, Callery PS. Bland TM, et al. Among authors: haining rl. Biochem Pharmacol. 2005 Oct 1;70(7):1096-103. doi: 10.1016/j.bcp.2005.07.007. Biochem Pharmacol. 2005. PMID: 16112652

8

Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes.

Zhang WY, Tu YB, Haining RL, Yu AM. Zhang WY, et al. Among authors: haining rl. Drug Metab Dispos. 2009 Jan;37(1):1-4. doi: 10.1124/dmd.108.023663. Epub 2008 Oct 6. Drug Metab Dispos. 2009. PMID: 18838503 Free PMC article.

9

(+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.

Suzuki H, Kneller MB, Haining RL, Trager WF, Rettie AE. Suzuki H, et al. Among authors: haining rl. Drug Metab Dispos. 2002 Mar;30(3):235-9. doi: 10.1124/dmd.30.3.235. Drug Metab Dispos. 2002. PMID: 11854139

10

Differential activation of CYP2C9 variants by dapsone.

Hummel MA, Dickmann LJ, Rettie AE, Haining RL, Tracy TS. Hummel MA, et al. Among authors: haining rl. Biochem Pharmacol. 2004 May 15;67(10):1831-41. doi: 10.1016/j.bcp.2004.01.017. Biochem Pharmacol. 2004. PMID: 15130760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year